25
Participants
Start Date
April 9, 2021
Primary Completion Date
January 31, 2025
Study Completion Date
January 31, 2025
Observation without intervention
This study is a follow-up study without intervention.
University of Vienna, Vienna
Lead Sponsor
BlueSky Immunotherapies GmbH
INDUSTRY